| |
|
|
|
|
|
|
|||
|
Blood, 7 May 2009, Vol. 113, No. 19, pp. 4627-4636. Prepublished online as a Blood First Edition Paper on March 3, 2009; DOI 10.1182/blood-2008-10-183467.
Submitted October 9, 2008
Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, United States * Corresponding author; email: rford{at}mdanderson.org.
BLyS and its major receptor BAFF-R, have been shown to be critical for development and homeostasis of normal B-lymphocytes, and for cell growth and survival of neoplastic B-lymphocytes, but the biologic mechanisms of this ligand/receptor-derived intracellular signaling pathway(s) have not been completely defined. We have discovered that the BAFF-R protein was present in the cell nucleus, in addition to its integral presence in the plasma membrane and cytoplasm, in both normal and neoplastic B-cells. BAFF-R interacted with histone H3 and IKK
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||